Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Nagendrakumar Balasubramanian Singanallur"'
Autor:
Shahbaz Ahmed, Mohammad Suhail Khan, Savitha Gayathri, Randhir Singh, Sahil Kumar, Unnatiben Rajeshbhai Patel, Sameer Kumar Malladi, Raju S. Rajmani, Petrus Jansen van Vuren, Shane Riddell, Sarah Goldie, Nidhi Girish, Poorvi Reddy, Aditya Upadhyaya, Suman Pandey, Samreen Siddiqui, Akansha Tyagi, Sujeet Jha, Rajesh Pandey, Oyahida Khatun, Rohan Narayan, Shashank Tripathi, Alexander J. McAuley, Nagendrakumar Balasubramanian Singanallur, Seshadri S. Vasan, Rajesh P. Ringe, Raghavan Varadarajan
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Saturation suppressor mutagenesis was used to generate thermostable mutants of the SARS-CoV-2 spike receptor-binding domain (RBD). A triple mutant with an increase in thermal melting temperature of ~7°C with respect to the wild-type B.1 RBD and was
Externí odkaz:
https://doaj.org/article/f5b173c45f564f3cb20fc74fc1645467
Autor:
Alexander J. McAuley, Petrus Jansen van Vuren, Muzaffar-Ur-Rehman Mohammed, Faheem, Sarah Goldie, Shane Riddell, Nathan J. Gödde, Ian K. Styles, Matthew P. Bruce, Simran Chahal, Stephanie Keating, Kim R. Blasdell, Mary Tachedjian, Carmel M. O’Brien, Nagendrakumar Balasubramanian Singanallur, John Noel Viana, Aditya V. Vashi, Carl M. Kirkpatrick, Christopher A. MacRaild, Rohan M. Shah, Elizabeth Vincan, Eugene Athan, Darren J. Creek, Natalie L. Trevaskis, Sankaranarayanan Murugesan, Anupama Kumar, Seshadri S. Vasan
Publikováno v:
Viruses, Vol 14, Iss 11, p 2417 (2022)
The repurposing of licenced drugs for use against COVID-19 is one of the most rapid ways to develop new and alternative therapeutic options to manage the ongoing pandemic. Given circa 7817 licenced compounds available from Compounds Australia that ca
Externí odkaz:
https://doaj.org/article/f5bfde929e31460aa993d8fbbab0208e
Autor:
Anne Balkema-Buschmann, Kerstin Fischer, Leanne McNabb, Sandra Diederich, Nagendrakumar Balasubramanian Singanallur, Ute Ziegler, Günther M. Keil, Peter D. Kirkland, Maren Penning, Balal Sadeghi, Glenn Marsh, Jennifer Barr, Axel Colling
Publikováno v:
Microorganisms, Vol 10, Iss 6, p 1095 (2022)
Since the identification of Hendra virus (HeV) infections in horses in Australia in 1994, more than 80 outbreaks in horses have been reported, and four out of seven spillover infections in humans had a fatal outcome. With the availability of a subuni
Externí odkaz:
https://doaj.org/article/fc2f86f4b0f54b4893c46d9adf1356cd
Autor:
Petrus Jansen van Vuren, Alexander J. McAuley, Michael J. Kuiper, Nagendrakumar Balasubramanian Singanallur, Matthew P. Bruce, Shane Riddell, Sarah Goldie, Shruthi Mangalaganesh, Simran Chahal, Trevor W. Drew, Kim R. Blasdell, Mary Tachedjian, Leon Caly, Julian D. Druce, Shahbaz Ahmed, Mohammad Suhail Khan, Sameer Kumar Malladi, Randhir Singh, Suman Pandey, Raghavan Varadarajan, Seshadri S. Vasan
Publikováno v:
Viruses, Vol 14, Iss 4, p 800 (2022)
As existing vaccines fail to completely prevent COVID-19 infections or community transmission, there is an unmet need for vaccines that can better combat SARS-CoV-2 variants of concern (VOC). We previously developed highly thermo-tolerant monomeric a
Externí odkaz:
https://doaj.org/article/2df4e05229264ccda3bb05db3152785e
Autor:
Nagendrakumar Balasubramanian Singanallur, Phaedra Lydia Eblé, Anna Barbara Ludi, Bob Statham, Abdelghani Bin-Tarif, Donald P. King, Aldo Dekker, Wilna Vosloo
Publikováno v:
Viruses, Vol 14, Iss 1, p 97 (2022)
The recent emergence and circulation of the A/ASIA/G-VII (A/G-VII) lineage of foot-and-mouth disease virus (FMDV) in the Middle East has resulted in the development of homologous vaccines to ensure susceptible animals are sufficiently protected again
Externí odkaz:
https://doaj.org/article/36d9229bf53c42e58e1c8f0846527a3f
Autor:
Nagendrakumar Balasubramanian Singanallur, Aldo Dekker, Phaedra Lydia Eblé, Froukje van Hemert-Kluitenberg, Klaas Weerdmeester, Jacquelyn J Horsington, Wilna Vosloo
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1110 (2021)
Vaccination is one of the best approaches to control and eradicate foot-and-mouth disease (FMD). To achieve this goal, vaccines with inactivated FMD virus antigen in suitable adjuvants are being used in addition to other control measures. However, on
Externí odkaz:
https://doaj.org/article/c799d1a5e669483db658ce03a7a68d67
Autor:
Aldo Dekker, Beatriz Sanz-Bernardo, Nagendrakumar Balasubramanian Singanallur, Anna B. Ludi, Jacquelyn Horsington, Phaedra L. Eblé, Donald P. King, Wilna Vosloo
Publikováno v:
Vaccines, Vol 8, Iss 1, p 24 (2020)
Since 2015, outbreaks of foot-and-mouth disease (FMD) in the Middle East have been caused by a new emerging viral lineage, A/ASIA/G-VII. Invitro vaccine matching data indicated that this virus poorly matched (low r1-value) with vaccines that were bei
Externí odkaz:
https://doaj.org/article/dfb47020404041dca35a3152b8a72938
Autor:
Nagendrakumar Balasubramanian Singanallur, Kathie Burkett, Sheree Brown, Sarah-Jane Riddell, Glenn A. Marsh, Jennifer A. Barr, Rachel Layton, Lee Trinidad, Gough G. Au, James Watson, Alexander J. McAuley, Suzanne Lowther, Seshadri S. Vasan, Daniel S. Layton
Publikováno v:
ILAR Journal
This case report discusses Type I hypersensitivity in ferrets following exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inoculum, observed during a study investigating the efficacy of candidate COVID-19 vaccines. Following a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5dc2984b40b17ef5be53e691f8e0a2d
https://doi.org/10.1093/ilar/ilab019
https://doi.org/10.1093/ilar/ilab019
Autor:
Jacquelyn Horsington, Wilna Vosloo, Nagendrakumar Balasubramanian Singanallur, K. Weerdmeester, Froukje van Hemert-Kluitenberg, Aldo Dekker, P.L. Eblé
Publikováno v:
Vaccines, Vol 9, Iss 1110, p 1110 (2021)
Vaccines 2021 (2021) 9
Vaccines, 2021(9)
Vaccines
Volume 9
Issue 10
Vaccines 2021 (2021) 9
Vaccines, 2021(9)
Vaccines
Volume 9
Issue 10
Vaccination is one of the best approaches to control and eradicate foot-and-mouth disease (FMD). To achieve this goal, vaccines with inactivated FMD virus antigen in suitable adjuvants are being used in addition to other control measures. However, on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7ed45e11bcedcfe403339bceaeebaa3
https://www.mdpi.com/2076-393X/9/10/1110
https://www.mdpi.com/2076-393X/9/10/1110
Autor:
John-Sebastian Eden, Navneet K. Dhand, Nicole Brown, Mary Tachedjian, David T. Williams, Ibrahim Diallo, Kai Xu, Andrew C. Breed, Michelle Michie, Bethany A Horsburgh, Eric D Laing, Nagendrakumar Balasubramanian Singanallur, John Duncan Grewar, Philip N Britton, Brenda van der Heide, Raina K. Plowright, Ben Poole, Christopher C. Broder, Spencer L. Sterling, Edward J. Annand, Anne E. Jackson, Ina Smith, Karren M. Plain, Maximillian C. de Kantzow, C.J. Secombe, Cheryl A Jones, Alison J. Peel, Peter A. Reid, Louise E. Jackson, Alison Tweedie, Lianying Yan
A novel Hendra virus (HeV) variant was identified from a horse that suffered acute fatal disease consistent with HeV infection through multidisciplinary and interagency syndromic sentinel surveillance research. Novel molecular assays for HeV detectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fdc1674a625df749173cb033f2b0353
https://doi.org/10.1101/2021.07.16.452724
https://doi.org/10.1101/2021.07.16.452724
